Schattenkerk M E, Obertop H, Mud H J, Eijkenboom W M, van Andel J G, van Houten H
Br J Surg. 1987 Mar;74(3):165-8. doi: 10.1002/bjs.1800740305.
During the period 1978-1984, 525 patients referred with cancer of the oesophagus or gastro-oesophageal junction were assessed for operation and cure. After investigation, 276 patients were selected and operated upon, as a rule, 4 weeks after radiotherapy (40 Gy/4 weeks). In 224 patients (81 per cent) the oesophagus and cardia were resected and reconstructed with stomach (69 per cent), colon (21 per cent), free ileal graft (7 per cent) or Roux-en-Y-oesophagojejunostomy (3 per cent). The postresectional hospital mortality was 14 per cent in all patients and decreased to 5 per cent in 1983. Mortality was higher when the colon was used for reconstruction than when the stomach was used. By postresection staging, 82 patients were found to have stages I and II tumours and 142 patients stage III tumours. Estimated 3-year survival after resection for all male patients was 28 per cent and for all female patients was 42 per cent. Estimated 3-year survival for all patients treated for adenocarcinoma was 31 per cent. Survival was better for stages I and II patients with adenocarcinoma (52 per cent) than for stage III patients (18 per cent) (P less than 0.01). Estimated 3-year survival for all patients treated for squamous cell carcinoma was 33 per cent. Estimated 3-year survival was better for stages I and II patients with squamous cell carcinoma (48 per cent) than for stage III patients (25 per cent) (P less than 0.001). It can be concluded from this study that resection of oesophagus and cardia after radiotherapy offers hope for cure in a subgroup of patients with non-advanced oesophageal cancer. The operation can be performed with acceptable mortality by experienced surgeons, especially when the stomach is used for reconstruction.
1978年至1984年期间,对525例因食管癌或胃食管交界癌前来就诊的患者进行了手术及治愈可能性评估。经检查后,挑选出276例患者进行手术,通常在放疗(40 Gy/4周)4周后进行。224例患者(81%)接受了食管和贲门切除,并分别用胃(69%)、结肠(21%)、游离回肠移植(7%)或Roux-en-Y食管空肠吻合术(3%)进行重建。所有患者术后住院死亡率为14%,1983年降至5%。用结肠重建时的死亡率高于用胃重建时。根据术后分期,发现82例患者为Ⅰ期和Ⅱ期肿瘤,142例患者为Ⅲ期肿瘤。所有男性患者切除术后的3年估计生存率为28%,所有女性患者为42%。所有接受腺癌治疗患者的3年估计生存率为31%。腺癌Ⅰ期和Ⅱ期患者的生存率(52%)高于Ⅲ期患者(18%)(P<0.01)。所有接受鳞状细胞癌治疗患者的3年估计生存率为33%。鳞状细胞癌Ⅰ期和Ⅱ期患者的3年估计生存率(48%)高于Ⅲ期患者(25%)(P<0.001)。从本研究可以得出结论,放疗后切除食管和贲门为一部分非晚期食管癌患者提供了治愈的希望。经验丰富的外科医生进行该手术时死亡率可接受,尤其是用胃进行重建时。